|
ES2344183A1
|
|
USE OF INSULIN SENSITIZING AGENTS VIA VAGINAL.
|
|
ES2344675A1
|
|
USE OF ESTRIOL IN THE PREPARATION OF A PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF VAGINAL ATROPHY IN WOMEN WITH RISK OF VARIUM VARCOLOGY.
|
|
MX2010005849A
|
|
Adapter for cannulas for dispensing products and cannula therefor.
|
|
WO2009060111A1
|
|
Suction nozzle and aspirator for removing nasal secretions from infants using a device that does not cause contamination or transmit pathogenic germs
|
|
ES2344673A1
|
|
USE OF ESTRIOL IN THE PREPARATION OF A PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF VAGINAL ATROPHY IN WOMEN WITH RISK OF POTOLOGIATUMORAL.
|
|
ES2310968A1
|
|
USE OF ESTRIOL IN LOW DOSE.
|
|
ES2279730A1
|
|
USE OF SULFONIC ACID DERIVATIVES IN THE TREATMENT OF OCULAR VASOPROLIFERATIVE DISEASES.
|
|
ES2275443A1
|
|
LIPOSOMAS PREPARATION PROCEDURE.
|
|
ES2272156A1
|
|
MICROPARTICULAR SYSTEMS.
|
|
US2007224255A1
|
|
Liposomal Formulations
|
|
ES2254027A1
|
|
LIPOSOMAL FORMULATIONS.
|
|
ES2255429A1
|
|
COMPOSITIONS PHARMACEUTICAL BUCODISPERSABLES.
|
|
ES2241488A1
|
|
LIPOSOMAL FORMULATIONS.
|
|
WO2004078704A1
|
|
Pharmaceutical compositions containing sulphonic acid derivatives
|
|
ES2237298A1
|
|
SEMISOLID MUCOADHESIVE FORMULATIONS.
|
|
ES2192136A1
|
|
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF OSTEOPOROSIS.
|
|
CH649917A5
|
|
Pharmaceutical formulations containing the coenzyme Q(10) suitable for topical administration
|
